Global Biopharmaceutical Contract Manufacturing Markets

Frost & Sullivan, January 2008, Pages: 57

This research service provides revenue and capacity forecasts for biopharmaceutical CMOs globally, by product type and region. It also provides growth drivers, market trends and a cost analysis.

1 GLOBAL BIOPHARMACEUTICAL CONTRACT MANUFACTURING MARKETS
- Introduction and Scope
- - Title
- - Disclaimer
- - Certification
- - Table of Contents
- - Research Scope and Methodology
- Overview
- - Title
- - Contract Manufacturing Organizations and Biopharmaceuticals
- Market Trends
- - Title
- - Investment
- - Transition
- - Biogenerics
- Growth Drivers
- - Title
- - Growth Drivers
- Revenue Forecasts
- - Title
- - Forecast Assumptions
- - Global Biopharmaceuticals Market Revenue Forecasts and Analysis
- - Global Mammalian Biopharmaceuticals Market Revenue Forecasts and Analysis
- - Global Microbial Biopharmaceuticals Market Revenue Forecasts and Analysis
- - Global Biopharmaceutical Contract Manufacturing Revenue Forecasts and Analysis
- - Market Engineering Measurements
- - Global Mammalian Cell Contract Manufacturing Market Revenue Forecasts
- - Global Microbial Contract Manufacturing Market Revenue Forecasts
- - CMO Segment Analysis
- - Manufacturing Cost Breakdown Mammalian Cell Manufacturing
- - Average Cost of Production of Biopharmaceuticals
- - CMO Cost Analysis
- Capacity Forecasts
- - Title
- - Global Captive Biomanufacturing Capacity Forecasts
- - Global Mammalian Cell Manufacturing Capacity Forecasts
- - Global CMO Mammalian Cell Manufacturing Capacity Forecasts
- - Global Biomanufacturing Capacity Utilization Forecasts
- - Capacity Forecasts Analysis
- Capacity Market Share Analysis
- - Title
- - Global CMO Mammalian Cell Manufacturing Capacity Market Share
- - Global Total Mammalian Cell Manufacturing Capacity Market Share
- Regional Share Analysis
- - Title
- - Global Biopharmaceutical Revenue Share
- - Global Biopharmaceutical R&D Share
- - Global Biopharmaceutical Companies by Region
- Conclusion
- - Title
- - Conclusion
- - Future Competitive Landscape
- Appendix
- - About Frost and Sullivan

Customers who bought this item also bought

• The State of Mammalian Cell Culture Biomanufacturing
• Biopharmaceutical Manufacturing in India, China and South Korea - Regulatory Framework, Infrastructure Support and Discovery Funding Create an Environment Conducive to Growth
• Upstream Processing in Biopharmaceuticals - Increasing use of Low-Cost Disposable Bioreactors to Drive the Upstream Bioprocessing Market
• Downstream Processing in Biopharmaceuticals - Increased Demand for Biologics Drives Improvement in Cost - Effective Purification Technologies
• The CMO Market Outlook: Emerging Markets, Key Players and Future Trends
• Downstream Processing in Biopharmaceuticals - Adoption of Disposable Technology at Improved Economies of Scale to Optimize Production Efficiency and Cost-effectiveness
• The Contract Biomanufacturing Market Outlook to 2017
• Contract Manufacturing Organizations to 2018 - Cost Advantages and Improving Quality Standards Build Confidence and Encourage Foreign Investment in Asian CMOs
• Manufacturing of Biologics - Increasing Demand for Monoclonal Antibodies and Recombinant Proteins Drives Increases in Capacities and Innovative Production Technologies
• European Pharmaceutical and Biotech Contract Manufacturing Markets